Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Hinge Health (HNGE) Asset Writedowns and Impairment (2024)

Hinge Health (HNGE) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $1.3 million as the latest value for Q2 2024.

Quarterly Asset Writedowns and Impairment changed N/A to $1.3 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Jun 2025, changed N/A year-over-year, with the annual reading at $1.8 million for FY2024, 82.35% down from the prior year.
Asset Writedowns and Impairment hit $1.3 million in Q2 2024 for Hinge Health.
In the past five years, Asset Writedowns and Impairment ranged from a high of $1.3 million in Q2 2024 to a low of $1.3 million in Q2 2024.